• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defining the scourge of COVID-19 hyperinflammatory syndrome.

作者信息

Cron Randy Q, Schulert Grant S, Tattersall Rachel S

机构信息

Division of Rheumatology, Children's of Alabama and Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.

Division of Rheumatology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

出版信息

Lancet Rheumatol. 2020 Dec;2(12):e727-e729. doi: 10.1016/S2665-9913(20)30335-0. Epub 2020 Sep 29.

DOI:10.1016/S2665-9913(20)30335-0
PMID:33015644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524518/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76a/7524518/68c422266314/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76a/7524518/68c422266314/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76a/7524518/68c422266314/fx1.jpg

相似文献

1
Defining the scourge of COVID-19 hyperinflammatory syndrome.定义新冠病毒超炎症综合征的危害
Lancet Rheumatol. 2020 Dec;2(12):e727-e729. doi: 10.1016/S2665-9913(20)30335-0. Epub 2020 Sep 29.
2
COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?儿童新冠病毒肺炎与高炎症综合征：伪装成巨噬细胞活化综合征的川崎病？
Cureus. 2020 Aug 1;12(8):e9515. doi: 10.7759/cureus.9515.
3
Defining COVID-19-associated hyperinflammatory syndrome in specific populations.定义特定人群中与新冠病毒相关的高炎症综合征。
Lancet Rheumatol. 2021 Sep;3(9):e609-e611. doi: 10.1016/S2665-9913(21)00157-0. Epub 2021 May 28.
4
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes.一种通过靶向白三烯减轻对COVID-19过度炎症反应的新策略。
Front Pharmacol. 2020 Aug 6;11:1214. doi: 10.3389/fphar.2020.01214. eCollection 2020.
5
Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19.色氨酸代谢对托珠单抗治疗COVID-19疗效的潜在益处。
Front Pharmacol. 2020 Jun 19;11:959. doi: 10.3389/fphar.2020.00959. eCollection 2020.
6
Efficacy of Dibrom, Trumpet, and Scourge against four mosquito species in Louisiana.二溴磷、喇叭牌和天灾牌杀虫剂对路易斯安那州四种蚊虫的防治效果
J Am Mosq Control Assoc. 1999 Dec;15(4):433-6.
7
The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?糖尿病大流行时期的新冠疫情：可能是异卵双胞胎吗？
Pathogens. 2020 May 19;9(5):389. doi: 10.3390/pathogens9050389.
8
Repurposing Cancer Drugs for COVID-19.将抗癌药物用于治疗新冠肺炎
Cancer Discov. 2020 Nov;10(11):OF2. doi: 10.1158/2159-8290.CD-ND2020-016. Epub 2020 Sep 18.
9
Telemedicine in Otorhinolaryngological Practice during COVID-19 Pandemic.新冠疫情期间耳鼻咽喉科实践中的远程医疗
Niger Med J. 2020 May-Jun;61(3):111-113. doi: 10.4103/nmj.NMJ_201_20. Epub 2020 Jul 4.

引用本文的文献

1
Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome.重症 COVID-19 细胞因子风暴综合征中的噬血细胞性淋巴组织细胞增生症基因变异
Viruses. 2025 Aug 8;17(8):1093. doi: 10.3390/v17081093.
2
IL-1 Family Blockade in Cytokine Storm Syndromes.白细胞介素-1 家族阻断在细胞因子风暴综合征中的应用。
Adv Exp Med Biol. 2024;1448:553-563. doi: 10.1007/978-3-031-59815-9_36.
3
COVID-19 Pneumonia and Cytokine Storm Syndrome.新型冠状病毒肺炎及细胞因子风暴综合征

本文引用的文献

1
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.新型冠状病毒肺炎相关过度炎症综合征的临床标准：一项队列研究
Lancet Rheumatol. 2020 Dec;2(12):e754-e763. doi: 10.1016/S2665-9913(20)30343-X. Epub 2020 Sep 29.
2
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
3
On the Alert for Cytokine Storm: Immunopathology in COVID-19.警惕细胞因子风暴：COVID-19 的免疫病理学。
Adv Exp Med Biol. 2024;1448:307-319. doi: 10.1007/978-3-031-59815-9_22.
4
The Multifaceted Immunology of Cytokine Storm Syndrome.细胞因子风暴综合征的多方面免疫学。
J Immunol. 2023 Apr 15;210(8):1015-1024. doi: 10.4049/jimmunol.2200808.
5
Effect of Pirfenidone on Risk of Pulmonary Fibrosis in COVID-19 Patients Experiencing Cytokine Storm.吡非尼酮对经历细胞因子风暴的COVID-19患者肺纤维化风险的影响。
Healthcare (Basel). 2022 Nov 28;10(12):2387. doi: 10.3390/healthcare10122387.
6
Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）发病和死亡的早期常规生物标志物：急诊科的结果
Diagnostics (Basel). 2022 Jan 12;12(1):176. doi: 10.3390/diagnostics12010176.
7
Who, what, and when-effective therapy for severe COVID-19.针对重症新型冠状病毒肺炎的有效治疗方法：适用人群、治疗手段及治疗时机
Lancet Rheumatol. 2022 Jan;4(1):e2-e3. doi: 10.1016/S2665-9913(21)00353-2. Epub 2021 Nov 17.
8
Modeling Virus-Induced Inflammation in Zebrafish: A Balance Between Infection Control and Excessive Inflammation.在斑马鱼中模拟病毒诱导的炎症：感染控制与过度炎症之间的平衡。
Front Immunol. 2021 May 7;12:636623. doi: 10.3389/fimmu.2021.636623. eCollection 2021.
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. doi: 10.1002/art.41285. Epub 2020 May 10.
4
The genetics of macrophage activation syndrome.巨噬细胞活化综合征的遗传学。
Genes Immun. 2020 May;21(3):169-181. doi: 10.1038/s41435-020-0098-4. Epub 2020 Apr 15.
5
The Rheumatologist's Role in COVID-19.风湿病学家在COVID-19中的作用。
J Rheumatol. 2020 May 1;47(5):639-642. doi: 10.3899/jrheum.200334. Epub 2020 Mar 24.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.小儿巨噬细胞活化综合征：认识冰山一角
Eur J Rheumatol. 2020 Feb;7(Suppl1):S13-S20. doi: 10.5152/eurjrheum.2019.19150.
8
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.铁蛋白与红细胞沉降率比值：识别全身型幼年特发性关节炎中巨噬细胞活化综合征的简易指标
ACR Open Rheumatol. 2019 Jul 13;1(6):345-349. doi: 10.1002/acr2.11048. eCollection 2019 Aug.
9
Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome.噬血细胞性淋巴组织细胞增生症——一种被低估的炎症综合征。
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi23-vi30. doi: 10.1093/rheumatology/kez379.
10
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.生物疗法对与全身型幼年特发性关节炎相关的巨噬细胞活化综合征的临床和实验室特征的影响。
Arthritis Care Res (Hoboken). 2018 Mar;70(3):409-419. doi: 10.1002/acr.23277. Epub 2018 Jan 30.